Abstract
Since 1996, the availability of combination antiretroviral therapy (cART) has led to improvements in immune status among HIV-infected persons, reducing AIDS-related morbidity and prolonging survival. However, despite the impact of cART on HIV-related mortality, malignancies remain an important cause of death in the current era. The use of cART was also associated with reduced incidence of the two major AIDS-associated malignancies - Kaposi's sarcoma (KS) and high-grade non-Hodgkin lymphoma (NHL). However, among non-AIDS-defining cancers, an increased risk of Hodgkin lymphoma (HL), anal cancer, lung cancer, and liver cancer has been observed.
Original language | English |
---|---|
Title of host publication | Hodgkin Lymphoma: A Comprehensive Overview, Second Edition |
Publisher | Springer International Publishing |
Pages | 307-318 |
Number of pages | 12 |
ISBN (Print) | 9783319125053, 9783319125046 |
DOIs | |
Publication status | Published - Jan 1 2015 |
ASJC Scopus subject areas
- Medicine(all)